Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesCurrent TaxesFinished GoodsGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury SharesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Immucell (ICCC) Current Leases (2020 - 2025)

Historic Current Leases for Immucell (ICCC) over the last 6 years, with Q3 2025 value amounting to $82442.0.

  • Immucell's Current Leases fell 8290.45% to $82442.0 in Q3 2025 from the same period last year, while for Sep 2025 it was $82442.0, marking a year-over-year decrease of 8290.45%. This contributed to the annual value of $432072.0 for FY2024, which is 3293.68% down from last year.
  • As of Q3 2025, Immucell's Current Leases stood at $82442.0, which was down 8290.45% from $322753.0 recorded in Q2 2025.
  • In the past 5 years, Immucell's Current Leases ranged from a high of $644276.0 in Q4 2023 and a low of $22920.0 during Q3 2022
  • Moreover, its 5-year median value for Current Leases was $108012.0 (2021), whereas its average is $227735.4.
  • Its Current Leases has fluctuated over the past 5 years, first soared by 192832.14% in 2023, then tumbled by 8290.45% in 2025.
  • Immucell's Current Leases (Quarter) stood at $108012.0 in 2021, then plummeted by 70.59% to $31764.0 in 2022, then soared by 1928.32% to $644276.0 in 2023, then tumbled by 32.94% to $432072.0 in 2024, then tumbled by 80.92% to $82442.0 in 2025.
  • Its last three reported values are $82442.0 in Q3 2025, $322753.0 for Q2 2025, and $380958.0 during Q1 2025.